annb0t
Top 20
Henry Schein, Inc. HSIC recently completed the acquisition of substantially all of the assets of Acentus, a national medical supplier specializing in the delivery of continuous glucose monitors (CGMs). Henry Schein anticipates the transaction to be neutral to 2025 non-GAAP earnings per share and accretive thereafter. Financial terms have not been disclosed.
The latest acquisition expands Henry Scheinâs Home Solutions business.
HSICâs Likely Stock Trend Following the News
Following t...
>>> Read more: HSIC Stock Might Rise Following the Acquisition of Acentus
The latest acquisition expands Henry Scheinâs Home Solutions business.
HSICâs Likely Stock Trend Following the News
Following t...
>>> Read more: HSIC Stock Might Rise Following the Acquisition of Acentus
